DNA repair genes XRCC1 and XRCC3 polymorphisms and their relationship with the level of micronuclei in breast cancer patients

Genetics and Molecular Biology

Volumn 33, Issue 4, 2010, Pages 637-640

  Santos, Raquel A ^a   Teixeira, Ana Claudia ^a   Mayorano, Monica B ^a   Carrara, Helio H A ^a   Andrade, Jurandyr M ^a   Takahashi, Catarina S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast cancer; DNA repair polymorphisms; Micronucleus assay

Indexed keywords

ARGININE; CYSTEINE; GLYCINE; METHIONINE; THREONINE; XRCC1 PROTEIN; XRCC3 PROTEIN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER RISK; CHROMOSOME DAMAGE; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MICRONUCLEUS TEST; PENETRANCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79251583132     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572010005000082     Document Type: Article

References (18)

1. Boffeta P (2009) Biomarkers in cancer epidemiology: An integrative approach. Carcinogenesis 131:121-126.
2. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, et al. (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625-631.
3. Caldecott KW (2003) XRCC1 and DNA strand break repair. DNA Repair 18:955-69.
4. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA and Easton DF (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:843-854.
5. Fenech M and Morley A (1985) Measurement of micronuclei in lymphocytes. Mutat Res 147:29-36.
6. Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455:81-95.
7. Hulka BS and Moorman PG (2001) Breast cancer: Hormones and other risk factors. Maturitas 38:103-116.
8. Kang HJ, Kim SW, Kim HJ, Ahn SJ, Bae JY, Park SK, Kang D, Hirvonen A, Choe KJm and Noh DY (2002) Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk. Cancer Lett 178:175-180.
9. Kristensen NS and Borresen-Dale AL (2000) Molecular epidemiology of breast cancer: Genetic variation in steroid hormone metabolism. Mutat Res 462:323-333.
10. Mateuca RA, Roelants M, Iarmarcovai G, Peter VA, Godderis L, Tremp A, Bonassi S, Fenech M, Lefranc JLB and Kirsch- VoldersM(2008) hOGG1326, XRCC1399 and XRCC3241 polymorphisms influence micronucleus frequencies in human lymphocytes in vivo. Mutagenesis 23:35-41.
11. Mitrunen K and Hirvonen A (2003) Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544:9-41.
12. Norppa H (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149:309-34.
13. Pachkowski BF, Winkel S, Kubota Y, Swenberg JA, Millikan RC and Nakamura J (2006) XRCC1 genotype and breast cancer: Functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res 66:2860-2868.
14. Santos RA, Teixeira AC, Mayorano MB, Carrara HH, Andrade JM and Takahashi CS (2010) Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women. Clin Exp Med 10:87-92.
15. Schild D, Lio YC, Collins DW, Tsomondo T and Chen DJJ (2000) Evidence for simultaneous protein interactions between human Rad51 paralogs. Biol Chem 275:16443-16449.
16. Synowiec E, Stefanska J, Morawiec Z, Blasiak J and Wozniak K (2008) Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res 648:65-72.
17. Teixeira AC, Dos Santos RA, Poersch A, Carrara HH, de Andrade JM and Takahashi CS (2009) DNA repair in Etoposide-induced DNA damage in lymphocytes of breast cancer patients and healthy women. Int J Clin Exp Med 20:280-288.
18. Thompson LH and Schild D (2002) Recombinational DNA repair and human disease. Mutat Res 509:49-78.